Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew S Chan

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|July 14, 2004
Ten years of alendronate treatment for osteoporosis in postmenopausal womenAndrew S Chan
The New England Journal of Medicine|November 4, 2005
Postmenopausal osteoporosisAndrew S Chan
The Journal of Biological Chemistry|September 9, 2006
C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinasesYuh-Ping Chong, Andrew S Chan, Khai-Chew Chan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|July 14, 2004
Ten years of alendronate treatment for osteoporosis in postmenopausal womenAndrew S Chan
The New England Journal of Medicine|November 4, 2005
Postmenopausal osteoporosisAndrew S Chan
The Journal of Biological Chemistry|September 9, 2006
C-terminal Src kinase-homologous kinase (CHK), a unique inhibitor inactivating multiple active conformations of Src family tyrosine kinasesYuh-Ping Chong, Andrew S Chan, Khai-Chew Chan, et al.
Pageof 1